Vectors in Biological Technology
Navigation Links
Vectors in Biological Technology
DNA2.0 Introduces Freedom of Expression With a New Family of Bacterial Expression Vect:ors
... A significant challenge utilizing pET vectors for bacterial expression has been the cost and uncertainty associated with vectors that have been patented. In order to tackle this problem, DNA2.0 has developed a new family of vectors called pJexpress that are free of IP constraints. ...Lentigen Corporation Receives Four Research Grants From the National Institutes of Health
... these diseases. For melanoma, HCV, and EBV, the vectors will transduce T cells, which play a central role ... to attack the targeted disease. For CLL, the vectors will carry weakened cells of this cancer combined ... in biotechnology and medicine. Lentiviral vectors are the most efficient vehicles for the delivery ...Lentigen Licenses Fundamental Lentiviral Vector Technology Patent From the University of Cambridge
... fundamental compositions of HIV-based lentiviral vectors that are currently widely used in research and ... About Lentiviral Vectors Lentiviral vectors (LV) are the most efficient vehicles for ... in biotechnology and medicine. Lentiviral vectors are the most efficient vehicles for the delivery ...... About Lentiviral Vectors Lentiviral vectors (LV) are vehicles that can deliver genes or ... non-viral, adenoviral and adeno-associated viral vectors have not been shown to achieve both high and ... in biotechnology and medicine. Lentiviral vectors are the most efficient vehicles for the delivery ...
Cell Genesys Announces Sale of Lentiviral Gene Delivery Technology for $12 Million
... therapy." About Lentiviral Vectors Lentiviral vectors are modified viruses that are used to transfer ... or in vivo. In preclinical studies, lentivirus vectors developed by Cell Genesys, have demonstrated ... capacity than certain other gene delivery vectors and therefore hold the potential to be used ...Lentigen Corporation Announces Relocation to New Facility
... growth needs as the leading developer and manufacturer of lentiviral vectors (LVs) and proteins for a wide range of clinical and research applications. ... and research applications in biotechnology and medicine. Lentiviral vectors are the most efficient vehicles for the delivery of genes or gene ...... be exploited to stringently regulate the expression of genes delivered by vectors used in gene therapy. With this approach expression of the Factor IX ... a mainstay of clinical medicine. Using adeno-associated viral (AAV) vectors as the delivery vehicle of choice for therapeutic genes, the company has ...
AMT Accesses Technology for Treatment of Duchenne Muscular Dystrophy
... Duchenne's disease in particular the combined application of snRNA and AAV vectors has shown tremendous promise. Access to La Sapienza's RNA technology ... a mainstay of clinical medicine. Using adeno-associated viral (AAV) vectors as the delivery vehicle of choice for therapeutic genes, the company has ...Vical Licensee AnGes MG Files NDA in Japan for Collategene Angiogenesis Product
... As for safety, we are using naked DNA delivery method instead of viral vectors to transfect genes, so that there won't be any safety concerns often caused by viral vectors in case of gene therapies. HGF is a gene therapy product originally ...On the trail of rogue genetically modified pathogens
... sensitivity and specificity, even when detecting previously unsequenced vectors in microarray-based bioassays. A new computational genomics tool was developed to compare all available sequenced artificial vectors with available natural sequences, including plasmids and chromosomes, from ...Lentigen to Move Headquarters and Manufacturing to Gaithersburg
... future growth needs as a leading developer and manufacturer of lentiviral vectors and proteins for a wide range of therapeutic and research applications. ... and research applications in biotechnology and medicine. Lentiviral vectors are the most efficient vehicles for the delivery of genes or gene ...Lentigen Appoints Tim Ravenscroft as Chief Executive Officer
... is poised to take a leading role in areas of biomedicine where Lentiviral vectors can play a decisive role. The company has a clear commitment to the ... and research applications in biotechnology and medicine. Lentiviral vectors are the most efficient vehicles for the delivery of genes or gene ...VIRxSYS and Lentigen Announce Litigation Settlement
... company focused on the manufacturing and development of lentiviral vectors using its proprietary gene delivery technology for a wide range of applications in biotechnology and medicine. Lentiviral vectors are highly adapted delivery vehicles that can transport genes or gene ...NASA technology helps predict and prevent future pandemic outbreaks
... areas, but also provides information about possible plague-carrying vectors -- such as insects or rodents -- globally and within the U.S. The Four ... the area, scientists can predict the food supply of disease transmitting vectors within the region and the threat they cause to humans. Because plague is ...... of fatigue, fevers, and chills (10-30%) reported. PROSTVAC(TM) is an 'off-the-shelf' viral vector-based immunotherapy, utilizing pox virus vectors that express PSA and three T cell costimulatory molecules are administered subcutaneously. An abstract from Professor Kantoff's presentation ...
Clontech Laboratories, Inc. Releases the Xfect(TM) and Xfect(TM) Stem Transfection Reagents
... of Xfect transfection reagents to our wide range of established products, including our Lenti-X(TM) and Adeno-X(TM) viral delivery systems and vectors for Tet-On(R) Advanced- and ProteoTuner(TM)-based inducible expression." Researchers recognize that effective, nontoxic DNA transfer is a vital ...... research. As a new molecular imaging technique, Cellvizio LAB can help monitor the interactions and effects of new molecules and new potential drug vectors non-invasively. Cellvizio LAB can also be used as high-throughput screening technique for mutant line maintenance. "VisualSonics has a great track ...
... self-renewal, and differentiation, as well as cytokines, antibodies, transfection reagents, and more. Stemgent's latest innovations include viral vectors encoding transcription factors necessary for the generation of induced pluripotent stem (iPS) cells. This unique product mix is designed to serve ...
... work has been ongoing with recombinant and fusion proteins for diagnostics and therapeutics, subunit and virus like particle (VLP) vaccines, vectors for gene therapy (retro-, lenti-, adeno- and, more recently, baculovirus) and stem cells for cell therapies (neuronal, hepatocytes). For more ...
GeneCopoeia Introduces Genome-Wide MicroRNA (miRNA) Functional Analysis Tools
... largest number of full-sequence-verified human and mouse full length protein coding ORF cDNA clones , which are offered to customers in more than 80 vectors with a choice of over 50 different fusion tags. Sun Lu, Ph. D. 19520 Amaranth Drive Germantown, Maryland 20874 USA Tel: ...Mosquito genes linked to insecticide resistance may be new target in fight against malaria
... has identified the genetic basis of resistance to common pyrethroid insecticides in the mosquito Anopheles funestus , one of the major malarial vectors in Africa. The group studied strains of An. funestus that are both susceptible and resistant to pyrethroids, and narrowed down the potential ...Lentigen and Expression Therapeutics Sign Hemophilia Co-Development Agreement
... of lentiviral vector technology for a wide range of therapeutic, vaccine, and research applications in biotechnology and medicine. Lentiviral vectors are the most efficient vehicles for the delivery of genes or gene silencing sequences stably into cells. Lentigen is a highly collaborative company, ...Imugene and Merial Establish Strategic Alliance
... of swine and poultry. Our relationship dates back to the very beginning of Imugene as a company, and we are confident that Imugene's adenoviral vectors have significant commercial potential for driving the development of important new products in animal health." About Merial Merial is ...... with PD experts from the US (6) and Europe (3). "Regardless of whether they're delivered via surgical implants, gene therapies, viral vectors or old-fashioned small molecules, the most dramatic advances in Parkinson's disease therapeutics will be used in early stage disease to prevent loss ...
... was founded in 2004 and is a development stage biotech company based in New York City. The Company is focused on developing Sindbis-based viral vectors as standalone oncolytic therapeutics, delivery systems for monoclonal antibodies and cytokines as well as cancer diagnostic products. The Sindbis ...
... was founded in 2004 and is a development stage biotech company based in New York City. The Company is focused on developing Sindbis-based viral vectors as standalone oncolytic therapeutics, delivery systems for monoclonal antibodies and cytokines as well as cancer diagnostic products. The Sindbis ...
... long-term interest in horizontal gene transfer among bacteria, Dr. Courvalin has been a thought leader in the area of using bacteria as intracellular vectors for delivery of DNA or proteins into mammalian cells. His laboratory was the first to describe the combination of invasin and listeriolysin to enable ...
... medical gene delivery. The latest scientific paper, entitled "Targeting metastatic cancer from the inside: A new generation of targeted gene delivery vectors enables personalized cancer vaccination in situ," was published in the October issue of the International Journal of Oncology (IJO). The paper ...
Amsterdam Molecular Therapeutics Reports Half Year Results 2008
... many if not all of the obstacles that have prevented gene therapy from becoming a mainstay of clinical medicine. Using adeno-associated viral (AAV) vectors as the delivery vehicle of choice for therapeutic genes, the company has been able to design and validate what is probably the first stable and ...AMT to Release Half Year 2008 Results on August 13, 2008
... many if not all of the obstacles that have prevented gene therapy from becoming a mainstay of clinical medicine. Using adeno-associated viral (AAV) vectors as the delivery vehicle of choice for therapeutic genes, the company has been able to design and validate what is probably the first stable and ...AMT Appoints Director Global Marketing and Sales
... many if not all of the obstacles that have prevented gene therapy from becoming a mainstay of clinical medicine. Using adeno-associated viral (AAV) vectors as the delivery vehicle of choice for therapeutic genes, the company has been able to design and validate what is probably the first stable and ...... many if not all of the obstacles that have prevented gene therapy from becoming a mainstay of clinical medicine. Using adeno-associated viral (AAV) vectors as the delivery vehicle of choice for therapeutic genes, the company has been able to design and validate what is probably the first stable and ...
A New President at the Head of the Genethon Laboratory
... is the promoter of the first gene therapy trial in humans for gamma-sarcoglycan deficiency. It possesses two clinical batch production units for vectors and is engaged in the development of a pre-industrial scale BMP production site to go onstream in 2010. http://www.genethon.com ...Lentigen Appoints Jim Meade as Vice President of Corporate Development
... of lentiviral vector technology for a wide range of therapeutic, vaccine, and research applications in biotechnology and medicine. Lentiviral vectors are the most efficient vehicles for the delivery of genes or gene silencing sequences stably into cells. Lentigen is a highly collaborative company, ...AMT Announces Presentations During the 11th Annual Meeting of the ASGT
... many if not all of the obstacles that have prevented gene therapy from becoming a mainstay of clinical medicine. Using adeno-associated viral (AAV) vectors as the delivery vehicle of choice for therapeutic genes, the company has been able to design and validate what is probably the first stable and ...AMT's Cooperative Research and Development Agreement With NIH to Boost Production Capacity
... many if not all of the obstacles that have prevented gene therapy from becoming a mainstay of clinical medicine. Using adeno-associated viral (AAV) vectors as the delivery vehicle of choice for therapeutic genes, the company has been able to design and validate what is probably the first stable and ...Amsterdam Molecular Therapeutics Part of Next Biotech Index
... many if not all of the obstacles that have prevented gene therapy from becoming a mainstay of clinical medicine. Using adeno-associated viral (AAV) vectors as the delivery vehicle of choice for therapeutic genes, the company has been able to design and validate what is probably the first stable and ...Amsterdam Molecular Therapeutics to Appoint George Morstyn to Supervisory Board
... many if not all of the obstacles that have prevented gene therapy from becoming a mainstay of clinical medicine. Using adeno-associated viral (AAV) vectors as the delivery vehicle of choice for therapeutic genes, the company has been able to design and validate what is probably the first stable and ...Amsterdam Molecular Therapeutics to Appoint Alexander Ribbink to Supervisory Board
... many if not all of the obstacles that have prevented gene therapy from becoming a mainstay of clinical medicine. Using adeno-associated viral (AAV) vectors as the delivery vehicle of choice for therapeutic genes, the company has been able to design and validate what is probably the first stable and ...Transgene in 2007: Partnership and Refinancing Position the Company for its Future Development
... development of its TG4001/R3484 therapeutic vaccine to treat HPV-mediated diseases. Transgene has bio-manufacturing capacities for viral-based vectors and technologies available for out-licensing. Additional information about Transgene is available on the Internet at http://www.transgene.fr . ...Other ContentsactinicactinicacupunctureacupunctureocclusionocclusionocclusionlymphocyticlymphocyticlymphocyticlymphocyticmountainmountainmountainmountainmountainlymphoblasticlymphoblasticlymphoblasticlymphoblasticmyelogenousmyelogenousmyelogenousnephriticOther TagsLinearLinearForcedForced
(Date:12/11/2009)... . , Montreal, December 11, 2009 ... prevents cancer. In the December 11 edition of the ... Universit de Montral and the Universit de Sherbrooke explain ... cancer-causing activity of cytokines, hormones that are culprits in ... and people exposed to asbestos. , "Excessive cytokine ...
(Date:12/11/2009)... editor of the 4th edition of Springer,s classic reference ... given the Victor A. McKusick Leadership Award. The prize, ... of human genetics, was presented to him at the ... Genetics on 24 October 2009 in Honolulu, Hawaii. , ... at the University of Washington in Seattle. One of ...
(Date:12/11/2009)... have traditionally been limited by the seasons, ... can be short. Thanks to researchers and ... introduced that offer growers the ability to ... bonuses for both producers and consumers. Fresh ... called "primocane-fruiting", which bear fruit on current-season ...
Breaking Biology News(10 mins):Scientists identify natural anti-cancer defenses 2New management methods extend blackberry season 2Keystone Mercy Health Plan Initiative Brings Cancer Screenings to Underserved Women in Their Communities 59860 1Keystone Mercy Health Plan Initiative Brings Cancer Screenings to Underserved Women in Their Communities 59860 2Keystone Mercy Health Plan Initiative Brings Cancer Screenings to Underserved Women in Their Communities 59860 3Keystone Mercy Health Plan Initiative Brings Cancer Screenings to Underserved Women in Their Communities 59860 4Karmanos Cancer Institute Immunology Researcher Obtains Nearly 241 Million National Institutes of Health Grant 59855 1Karmanos Cancer Institute Immunology Researcher Obtains Nearly 241 Million National Institutes of Health Grant 59855 2Karmanos Cancer Institute Immunology Researcher Obtains Nearly 241 Million National Institutes of Health Grant 59855 3Pulmo BioTech Inc Announces Letter of Intent Regarding Proposed License of its Pulmonary Vascular Diagnostic Product Candidate PulmoBind 28TM 29 5618 1Pulmo BioTech Inc Announces Letter of Intent Regarding Proposed License of its Pulmonary Vascular Diagnostic Product Candidate PulmoBind 28TM 29 5618 2Pulmo BioTech Inc Announces Letter of Intent Regarding Proposed License of its Pulmonary Vascular Diagnostic Product Candidate PulmoBind 28TM 29 5618 3Pulmo BioTech Inc Announces Letter of Intent Regarding Proposed License of its Pulmonary Vascular Diagnostic Product Candidate PulmoBind 28TM 29 5618 4(Date:12/14/2009)... Adults, Attitudes and Behavior Regarding Pregnancy, Contraception, and Related ... Nearly all unmarried young adults ages 18-29 believe pregnancy ... and 86% of women) and say that it is ... (86% of men and 88% of women), according to ... Teen and Unplanned Pregnancy. Even so: ,, ...
(Date:12/14/2009)... oxygen, drugs, and more… , ... ... in collaboration with scientists at University of Michigan, have developed ... of natural red blood cells, including softness, flexibility, and the ... primary function of natural red blood cells is to carry ...
(Date:12/14/2009)... ARBOR, Mich., Dec. 14 Pepsi ... the Commonwealth of Kentucky are among the major ... this fall to help their employees make better ... solution gives employees a personalized summary of their ... of that care. With this personalized information, employees ...
(Date:12/14/2009)... -- Americold Realty Trust ("Americold") announced today that it ... the U.S. Securities and Exchange Commission (the "SEC") relating ... shares. The number of shares to be offered and ... been determined. The common shares to be sold in ... ,, The joint book-running managers of the offering ...
(Date:12/14/2009)... BRAINTREE, Mass., Dec. 14 Haemonetics Corporation ... it has filed a new legal action to ... Fenwal,s just released red cell collection kits, using ... its separation chamber to circumvent Haemonetics, patent and ... continued sale of infringing products after December 1, ...
Breaking Medicine News(10 mins):Health News:Although Most Unmarried Young Adults Want to Avoid Pregnancy, Many Don't Use Contraception, Know Little About It, and Think It Doesn't Make Much Difference 2Health News:Although Most Unmarried Young Adults Want to Avoid Pregnancy, Many Don't Use Contraception, Know Little About It, and Think It Doesn't Make Much Difference 3Health News:Synthetic Red Blood Cells Developed 2Health News:Synthetic Red Blood Cells Developed 3Health News:Corporations, Universities and State Governments Deploy Thomson Reuters Solution to Improve Employees' Benefit Selection Process 2Health News:Americold Realty Trust Files Registration Statement for Proposed Initial Public Offering 2Health News:Haemonetics Files a New Legal Action to Stop Fenwal Inc.'s Continued Patent Infringement 2Health News:Haemonetics Files a New Legal Action to Stop Fenwal Inc.'s Continued Patent Infringement 3[1] Although Most Unmarried Young Adults Want to Avoid Pregnancy, Many Don't Use Contraception, Know Little About It, and Think It Doesn't Make Much Difference[0] Synthetic Red Blood Cells Developed [0] Corporations, Universities and State Governments Deploy Thomson Reuters Solution to Improve Employees' Benefit Selection Process[0] Americold Realty Trust Files Registration Statement for Proposed Initial Public Offering[0] Haemonetics Files a New Legal Action to Stop Fenwal Inc.'s Continued Patent Infringement
EnPulseEnRhythmINSIGNIALinearPrometheusGastrodiagnosticBilitecDigitrapperOXOIDTISSUEscopeCAPILLARYSCellTracksForcedPrismPipette
Other Tagsdisabled 2disabled 3disabled 4disabled 5solved 2solved 3faced 2faced 3creature 2onto 2onto 3onto 4onto 5onto 6onto 7onto 8onto 9onto 10| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |